Kazia Therapeutics (KZIA) Liabilities and Shareholders Equity (2009 - 2025)
Kazia Therapeutics (KZIA) recorded Liabilities and Shareholders Equity of $46.69 million in the quarter ended Dec 31, 2025.
Powered by 
Analysis
Kazia Therapeutics (KZIA) Liabilities and Shareholders Equity (2009 - 2025) Analysis & Trends
As of Jun 30, 2025, Kazia Therapeutics reported Liabilities and Shareholders Equity of $3.88 million.
- Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of -24.6% (years ended Jun 2020 to Jun 2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $14.12 million in the year ended Dec 31, 2024 (-22.8%), $18.28 million in the year ended Dec 31, 2023 (-26.7%), $24.94 million in the year ended Dec 31, 2022 (-25.7%) and $33.57 million in the year ended Dec 31, 2021 (+110.7%).
- The figure for the quarter ended Dec 31, 2025 is the highest quarterly Liabilities and Shareholders Equity in data going back to the quarter ended Jun 30, 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Kazia Therapeutics | 69.81 Mn | 69.81 Mn | - | 46.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 46.69 Mn |
| Jun 30, 2025 | 3.88 Mn |
| Dec 31, 2024 | 14.12 Mn |
| Jun 30, 2024 | 14.23 Mn |
| Dec 31, 2023 | 18.28 Mn |
| Jun 30, 2023 | 18.77 Mn |
| Dec 31, 2022 | 23.58 Mn |
| Jun 30, 2022 | 25.71 Mn |
| Dec 31, 2021 | 32.54 Mn |
| Jun 30, 2021 | 44.73 Mn |
| Dec 31, 2020 | 16.86 Mn |
| Jun 30, 2020 | 15.12 Mn |
| Dec 31, 2019 | 14.47 Mn |
| Jun 30, 2019 | 14.83 Mn |
| Dec 31, 2018 | 18.36 Mn |
| Jun 30, 2018 | 21.33 Mn |
| Dec 31, 2017 | 27.62 Mn |
| Jun 30, 2017 | 26.98 Mn |
| Dec 31, 2016 | 26.64 Mn |
| Jun 30, 2016 | 35.91 Mn |
API Access
Kazia Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KZIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "KZIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KZIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();